These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 3436054)
21. Body mass index modulates the relationship of sugar-sweetened beverage intake with serum urate concentrations and gout. Dalbeth N; Phipps-Green A; House ME; Gamble GD; Horne A; Stamp LK; Merriman TR Arthritis Res Ther; 2015 Sep; 17(1):263. PubMed ID: 26391224 [TBL] [Abstract][Full Text] [Related]
22. Clinical value of the measurement of bone remodelling markers in primary hyperparathyroidism. Minisola S; Scarnecchia L; Carnevale V; Bigi F; Romagnoli E; Pacitti MT; Rosso R; Mazzuoli GF J Endocrinol Invest; 1989 Sep; 12(8):537-42. PubMed ID: 2592739 [TBL] [Abstract][Full Text] [Related]
23. Changes in plasma urate, creatinine, alkaline phosphatase and the 24 hours excretion of hydroxyproline during sexual maturation in adolescents. Round JM Ann Hum Biol; 1980; 7(1):83-8. PubMed ID: 7396407 [TBL] [Abstract][Full Text] [Related]
24. Urate kinetics in hypoxanthine-guanine phosphoribosyltransferase deficiency: their significance for the understanding of gout. Emmerson BT; Gordon RB; Johnson LA Q J Med; 1976 Jan; 45(177):49-61. PubMed ID: 769040 [TBL] [Abstract][Full Text] [Related]
25. Primary hyperparathyroidism and proximal renal tubular acidosis: report of two cases. Siddiqui AA; Wilson DR Can Med Assoc J; 1972 Mar; 106(6):654-9. PubMed ID: 5012229 [TBL] [Abstract][Full Text] [Related]
26. Hereditary nephropathy associated with hyperuricemia and gout. Puig JG; Miranda ME; Mateos FA; Picazo ML; Jiménez ML; Calvin TS; Gil AA Arch Intern Med; 1993 Feb; 153(3):357-65. PubMed ID: 8427538 [TBL] [Abstract][Full Text] [Related]
27. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism. Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811 [TBL] [Abstract][Full Text] [Related]
29. Uricosuric therapy and urate solubility in blood and urine. Gröbner W; Zöllner N Postgrad Med J; 1979; 55 Suppl 3():26-31. PubMed ID: 504037 [TBL] [Abstract][Full Text] [Related]
30. Genetic control of the renal clearance of urate: a study of twins. Emmerson BT; Nagel SL; Duffy DL; Martin NG Ann Rheum Dis; 1992 Mar; 51(3):375-7. PubMed ID: 1575585 [TBL] [Abstract][Full Text] [Related]
31. Urinary hydroxyproline and serum alkaline phosphatase in sickle cell disease. Mohammed SM; Suleiman SA; Addae SK; Annobil SH; Adzaku FK; Kadoummi OF; Richards JT Clin Chim Acta; 1991 Dec; 203(2-3):285-94. PubMed ID: 1777988 [TBL] [Abstract][Full Text] [Related]
32. Bone turnover markers predict changes in bone mineral density after parathyroidectomy in patients with renal hyperparathyroidism. Lu KC; Ma WY; Yu JC; Wu CC; Chu P Clin Endocrinol (Oxf); 2012 May; 76(5):634-42. PubMed ID: 22007930 [TBL] [Abstract][Full Text] [Related]
33. Hypouricaemia and increased renal urate clearance associated with hyperparathyroidism. Gibson T; Sims HP; Jimenez SA Ann Rheum Dis; 1976 Aug; 35(4):372-6. PubMed ID: 970997 [TBL] [Abstract][Full Text] [Related]